BiotechTube

Pirfenidone

Pre-clinicalCompleted
0 watching 0 views this week๐Ÿ’ค Quiet
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Covid19

Conditions

Covid19, ARDS

Trial Timeline

Nov 8, 2020 โ†’ Dec 31, 2022

NCT ID
NCT04653831

About Pirfenidone

Pirfenidone is a pre-clinical stage product being developed by Roche for Covid19. The current trial status is completed. This product is registered under clinical trial identifier NCT04653831. Target conditions include Covid19, ARDS.

Hype Score Breakdown

Clinical
5
Activity
2
Company
10
Novelty
2
Community
1

Clinical Trials (8)

NCT IDPhaseStatus
NCT04653831Pre-clinicalCompleted
NCT03385668Phase 2Completed
NCT03208933Phase 3Completed
NCT03115619Pre-clinicalCompleted
NCT02525484Phase 1Completed
NCT02622477Pre-clinicalCompleted
NCT02699879Pre-clinicalCompleted
NCT00662038Phase 3Completed

Competing Products

20 competing products in Covid19

See all competitors
ProductCompanyStageHype Score
Favipiravir + NitazoxanideStrides PharmaPhase 2
51
Icosapent ethylAmarin CorporationApproved
77
GX-03 + Petrolatum ointmentTurn TherapeuticsPhase 2
44
Cytotoxic T LymphocytesTevogen BioPhase 1
25
DS-5670a + PlaceboDaiichi SankyoPhase 1/2
41
Pegylated Interferon-ฮฑ2bZydus LifesciencesPhase 2
52
BaricitinibEli LillyPhase 3
77
LY3819253 + Placebo + Remdesivir + VIR-7831 + BRII-196/BRII-198 + AZD7442 + MP0420 + PF-07304814Eli LillyPhase 3
77
bamlanivimabEli LillyApproved
85
1x10^9 vp AZD1222 + 5x10^9 vp AZD1222 + 1x10^10 vp AZD1222AstraZenecaPhase 1
33
Sacubitril / Valsartan Oral Tablet [Entresto] + PlaceboNovartisPhase 1/2
41
Remdesivir + Remdesivir Placebo + CorticosteroidGilead SciencesPhase 3
76
RemdesivirGilead SciencesPre-clinical
22
Remdesivir + Remdesivir Placebo + Aviptadil + Aviptadil Placebo + CorticosteroidGilead SciencesPhase 3
76
anti-COVID19 mRNA-based vaccine (BNT162b2, Comirnatyยฎ, commercialized by Pfizer)PfizerPhase 3
76
Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine + CoronaVac COVID-19 vaccine + ChAdOx1 nCoV-19 Covid-19 Vaccine + Ad26.COV2.S COVID-19 VaccinePfizerPre-clinical
22
Tofacitinib 10 mg + PlaceboPfizerPhase 3
76
BNT162b2PfizerPhase 2
51
Anakinra + 0.9% SalineSwedish Orphan BiovitrumPhase 2
51
COVID-19 vaccine Pfizer (3 doses) + COVID-19 vaccine Pfizer (2 doses) + COVID-19 mRNA Vaccine Moderna (3 doses) + COVID-19 mRNA Vaccine Moderna (2 doses) + COVID-19 mRNA Vaccine Moderna (1 dose)SanofiApproved
84

Other Products from Roche

EmicizumabApproved
85
rituximab + methotrexate + methylprednisolone + acetaminophen + antihistamineApproved
85
RituximabApproved
85
mycophenolate mofetil [CellCept]Approved
85
saquinavir/ritonavir + atazanavir/ritonavirApproved
85